Cannabis Bioscience International Holdings (CBIH) Total Liabilities (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Total Liabilities across 5 years of filings, most recently posting $1.5 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $1.5 million, up 18.4% year-over-year; the trailing twelve-month figure through Feb 2026 was $1.5 million (up 18.4% YoY), and the FY2025 annual result was $1.2 million, up 5.22% from the prior year.
• Total Liabilities came in at $1.5 million for Q1 2026 at Cannabis Bioscience International Holdings, up from $1.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.5 million in Q1 2026 to a low of $405301.0 in Q4 2022.
• The 5-year median for Total Liabilities is $1.1 million (2024), against an average of $1.0 million.
• Across the five-year window, Total Liabilities surged 132.85% in 2023 and increased 5.22% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Total Liabilities stood at $405301.0 in 2022, then soared by 132.85% to $943726.0 in 2023, then gained by 27.11% to $1.2 million in 2024, then rose by 15.48% to $1.4 million in 2025, then climbed by 6.02% to $1.5 million in 2026.
• The last three Total Liabilities figures came in at $1.5 million (Q1 2026), $1.4 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.